4.3 Article

The neuroprotective factor WId(s) does not attenuate mutant SOD1-mediated motor neuron disease

Journal

NEUROMOLECULAR MEDICINE
Volume 5, Issue 3, Pages 193-203

Publisher

HUMANA PRESS INC
DOI: 10.1385/NMM:5:3:193

Keywords

SOD1; Wallerian degeneration; motor neuron; amyotrophic lateral sclerosis (ALS); axon

Categories

Ask authors/readers for more resources

Selective degeneration and death of motor neurons in SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) is accompanied by axonal disorganization and reduced slow axonal transport in the three most frequently used mouse models of mutant SOD1-mediated ALS. To test whether suppression of axonal degeneration (frequently known as Wallerian degeneration) could slow disease development, we took advantage of a spontaneous mouse mutant WId(s) (Wallerian degeneration slow) in which the programmed axonal degenerative process that is normally activated after axonal injury is significantly delayed. Despite its effectiveness in delaying axonal loss in other neurodegenerative models, the presence of Wld(s) did not slow disease onset, ameliorate mutant motor neuron death, axonal degeneration, or preserve synaptic attachments in mice that develop disease from ALS-linked SOD1 mutants SOD1(G374) or SOD1(G85R). However, presynaptic endings in both the presence and absence of WlD(s) showed high accumulations of mitochondria and synaptic vesicles, implicating errors of retrograde transport as a consequence of SOD1-mutant damage to axons.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available